OnKure Therapeutics, Inc.
OKUR
$3.90
$0.000.00%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -5.05% | -3.37% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -8.88% | -5.04% | |||
| Operating Income | 8.88% | 5.04% | |||
| Income Before Tax | 8.14% | 4.49% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 8.14% | 4.49% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 8.14% | 4.49% | |||
| EBIT | 8.88% | 5.04% | |||
| EBITDA | 8.91% | 5.02% | |||
| EPS Basic | 8.58% | 4.64% | |||
| Normalized Basic EPS | 8.59% | 4.63% | |||
| EPS Diluted | 8.58% | 4.64% | |||
| Normalized Diluted EPS | 8.59% | 4.63% | |||
| Average Basic Shares Outstanding | 0.49% | 0.16% | |||
| Average Diluted Shares Outstanding | 0.49% | 0.16% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||